Richard Newitter
Stock Analyst at Truist Financial
(4.38)
# 1,264
Out of 4,604 analysts
1016
Total ratings
50%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Downgraded: Hold | $210 → $153 | $137.10 | +11.60% | 16 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $92 → $106 | $96.66 | +9.66% | 70 | Aug 6, 2026 | |
| CARL Carlsmed | Reiterated: Buy | $18 → $20 | $13.90 | +43.88% | 8 | Aug 6, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Hold | $21 | $19.41 | +8.19% | 42 | Aug 5, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $110 → $127 | $124.95 | +1.64% | 19 | Aug 4, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $125 → $103 | $101.07 | +1.41% | 60 | Aug 4, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $54 → $62 | $59.51 | +4.18% | 67 | Aug 4, 2026 | |
| SIBN SI-BONE | Reiterated: Buy | $21 → $23 | $17.81 | +29.14% | 17 | Aug 4, 2026 | |
| VCEL Vericel | Reiterated: Buy | $54 → $58 | $44.54 | +30.22% | 19 | Jul 31, 2026 | |
| DXCM DexCom | Reiterated: Buy | $87 → $93 | $83.13 | +11.87% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 → $340 | $335.85 | +1.24% | 49 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $62 → $57 | $49.72 | +14.64% | 52 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $215 | $169.93 | +26.52% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $13.89 | +58.39% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $88.92 | +6.84% | 41 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 → $510 | $375.55 | +35.80% | 73 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $79.52 | +25.75% | 55 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $125.14 | +27.86% | 33 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $4 | $4.34 | -7.83% | 36 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $86 | $86.18 | -0.21% | 48 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $18.75 | +65.33% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $22.26 | -10.15% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $140.54 | - | 65 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $325.10 | +15.04% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $65.20 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $17.40 | -25.29% | 33 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $105.09 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.51 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $259.52 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.27 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.90 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $148 | $179.80 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.39 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $6.00 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 57.24 → CHF 66.11 | CHF 56.42 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $140.40 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $177.47 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $44.43 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.73 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $171.76 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $49.51 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $107.59 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $40.22 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $27.31 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $256.76 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $5.17 | n/a | 1 | Jul 15, 2016 |
Insulet
Aug 6, 2026
Downgraded: Hold
Price Target: $210 → $153
Current: $137.10
Upside: +11.60%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $92 → $106
Current: $96.66
Upside: +9.66%
Carlsmed
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $20
Current: $13.90
Upside: +43.88%
PROCEPT BioRobotics
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $19.41
Upside: +8.19%
Integer Holdings
Aug 4, 2026
Downgraded: Hold
Price Target: $110 → $127
Current: $124.95
Upside: +1.64%
Lantheus Holdings
Aug 4, 2026
Downgraded: Hold
Price Target: $125 → $103
Current: $101.07
Upside: +1.41%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $62
Current: $59.51
Upside: +4.18%
SI-BONE
Aug 4, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $17.81
Upside: +29.14%
Vericel
Jul 31, 2026
Reiterated: Buy
Price Target: $54 → $58
Current: $44.54
Upside: +30.22%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $87 → $93
Current: $83.13
Upside: +11.87%
Jul 31, 2026
Reiterated: Hold
Price Target: $330 → $340
Current: $335.85
Upside: +1.24%
Jul 30, 2026
Rated: Buy
Price Target: $62 → $57
Current: $49.72
Upside: +14.64%
Jul 30, 2026
Reiterated: Buy
Price Target: $180 → $215
Current: $169.93
Upside: +26.52%
Jul 30, 2026
Reiterated: Buy
Price Target: $22
Current: $13.89
Upside: +58.39%
Jul 24, 2026
Reiterated: Hold
Price Target: $95
Current: $88.92
Upside: +6.84%
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $510
Current: $375.55
Upside: +35.80%
Jul 16, 2026
Maintained: Buy
Price Target: $100
Current: $79.52
Upside: +25.75%
Jul 16, 2026
Maintained: Buy
Price Target: $160
Current: $125.14
Upside: +27.86%
Jul 16, 2026
Maintained: Hold
Price Target: $2 → $4
Current: $4.34
Upside: -7.83%
Jun 4, 2026
Rated: Hold
Price Target: $86
Current: $86.18
Upside: -0.21%
May 11, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $18.75
Upside: +65.33%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $22.26
Upside: -10.15%
Feb 27, 2026
Maintained: Hold
Price Target: n/a
Current: $140.54
Upside: -
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $325.10
Upside: +15.04%
Jan 16, 2026
Maintained: Buy
Price Target: n/a
Current: $65.20
Upside: -
Dec 23, 2025
Reiterated: Hold
Price Target: $13
Current: $17.40
Upside: -25.29%
Jun 26, 2025
Maintained: Buy
Price Target: n/a
Current: $105.09
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $20.51
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $259.52
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $10.27
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $30.90
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $148
Current: $179.80
Upside: n/a
Oct 7, 2021
Maintained: Buy
Price Target: n/a
Current: $2.39
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $6.00
Upside: n/a
Aug 17, 2021
Maintained: Hold
Price Target: CHF 57.24 → CHF 66.11
Current: CHF 56.42
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $140.40
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $177.47
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $44.43
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $5.73
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $171.76
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $49.51
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $107.59
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $40.22
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $27.31
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $256.76
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $5.17
Upside: n/a